Muhammad A. Halwani

1.0k total citations
32 papers, 421 citations indexed

About

Muhammad A. Halwani is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Muhammad A. Halwani has authored 32 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Muhammad A. Halwani's work include Antibiotic Use and Resistance (5 papers), Antibiotic Resistance in Bacteria (5 papers) and COVID-19 Clinical Research Studies (4 papers). Muhammad A. Halwani is often cited by papers focused on Antibiotic Use and Resistance (5 papers), Antibiotic Resistance in Bacteria (5 papers) and COVID-19 Clinical Research Studies (4 papers). Muhammad A. Halwani collaborates with scholars based in Saudi Arabia, Pakistan and Malaysia. Muhammad A. Halwani's co-authors include Ali A. Rabaan, Mohammed Garout, Naveed Ahmed, Abbas Al Mutair, Richard Slack, Saad Alhumaid, Masoud Solaymani–Dodaran, Carol Coupland, Hajo Grundmann and Amer Alshengeti and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Frontiers in Pharmacology and Journal of Hospital Infection.

In The Last Decade

Muhammad A. Halwani

32 papers receiving 411 citations

Peers

Muhammad A. Halwani
Muhammad A. Halwani
Citations per year, relative to Muhammad A. Halwani Muhammad A. Halwani (= 1×) peers Patrick Chhatwal

Countries citing papers authored by Muhammad A. Halwani

Since Specialization
Citations

This map shows the geographic impact of Muhammad A. Halwani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad A. Halwani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad A. Halwani more than expected).

Fields of papers citing papers by Muhammad A. Halwani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad A. Halwani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad A. Halwani. The network helps show where Muhammad A. Halwani may publish in the future.

Co-authorship network of co-authors of Muhammad A. Halwani

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad A. Halwani. A scholar is included among the top collaborators of Muhammad A. Halwani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad A. Halwani. Muhammad A. Halwani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Alsahafi, Abdullah J., et al.. (2023). Use of Smartphone-Based Video Directly Observed Therapy to Increase Tuberculosis Medication Adherence: An Interventional Study. Galen Medical Journal. 12. e3067–e3067. 3 indexed citations
3.
Tallei, Trina Ekawati, Fatimawali Fatimawali, İsmail Çeli̇k, et al.. (2023). 4’-fluorouridine as a potential COVID-19 oral drug?: a review. F1000Research. 11. 410–410. 1 indexed citations
4.
Pal, Madhumita, Ahmed Mahal, Ranjan K. Mohapatra, et al.. (2023). Deep and Transfer Learning Approaches for Automated Early Detection of Monkeypox (Mpox) Alongside Other Similar Skin Lesions and Their Classification. ACS Omega. 8(35). 31747–31757. 27 indexed citations
5.
Dhawan, Manish, Ali A. Rabaan, Sara Alwarthan, et al.. (2023). Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID. Vaccines. 11(3). 699–699. 41 indexed citations
6.
Basha, Sakeenabi, Ali A. Rabaan, Muhammad A. Halwani, et al.. (2023). Prevalence of Carbapenemase and Extended-Spectrum β-Lactamase Producing Enterobacteriaceae: A Cross-Sectional Study. Antibiotics. 12(1). 148–148. 16 indexed citations
7.
Rabaan, Ali A., Muhammad A. Halwani, Mohammed Garout, et al.. (2023). Identification of natural potent inhibitors against Mycobacterium tuberculosis isocitrate lyase: an in silico study. Molecular Diversity. 28(5). 2783–2799. 1 indexed citations
8.
Das, Kuntal, Mansour Almuqbil, Mohd Imran, et al.. (2023). Nephroprotective potential of Polyalthia longifolia roots against vancomycin-induced renal toxicity in experimental animals. Frontiers in Pharmacology. 14. 1107435–1107435. 2 indexed citations
9.
Rabaan, Ali A., Muhammad A. Halwani, Mohammed Garout, et al.. (2023). Exploration of phytochemical compounds against Marburg virus using QSAR, molecular dynamics, and free energy landscape. Molecular Diversity. 28(5). 3261–3278. 17 indexed citations
10.
Chukwuocha, Uchechukwu Madukaku, Ramesh Kumar, Mohammed Amir Rais, et al.. (2023). Seasonal Variation and Geographical Distribution of COVID-19 across Nigeria (March 2020–July 2021). Vaccines. 11(2). 298–298. 2 indexed citations
11.
Rabaan, Ali A., Bashayer M. AlShehail, Muhammad A. Halwani, et al.. (2023). Investigation of Zika virus methyl transferase inhibitors using steered molecular dynamics. Journal of Biomolecular Structure and Dynamics. 42(4). 1711–1724. 1 indexed citations
12.
Tallei, Trina Ekawati, Bashayer M. AlShehail, Fatimawali Fatimawali, et al.. (2023). Immunoinformatics-Driven Strategies for Advancing Epitope-Based Vaccine Design for West Nile Virus. Journal of Pharmaceutical Sciences. 113(4). 906–917. 2 indexed citations
13.
Tallei, Trina Ekawati, Fatimawali Fatimawali, İsmail Çeli̇k, et al.. (2022). 4’-fluorouridine and its derivatives as potential COVID-19 oral drugs: a review. F1000Research. 11. 410–410. 2 indexed citations
14.
Rabaan, Ali A., Saad Alhumaid, Abbas Al Mutair, et al.. (2022). Application of Artificial Intelligence in Combating High Antimicrobial Resistance Rates. Antibiotics. 11(6). 784–784. 70 indexed citations
15.
Rabaan, Ali A., Muhammed A. Bakhrebah, Mohammed Garout, et al.. (2022). Global Prevalence of Colistin Resistance in Klebsiella pneumoniae from Bloodstream Infection: A Systematic Review and Meta-Analysis. Pathogens. 11(10). 1092–1092. 43 indexed citations
16.
Naveed, Muhammad, Urooj Ali, Ali A. Rabaan, et al.. (2022). Execution and Design of an Anti HPIV-1 Vaccine with Multiple Epitopes Triggering Innate and Adaptive Immune Responses: An Immunoinformatic Approach. Vaccines. 10(6). 869–869. 23 indexed citations
17.
Rabaan, Ali A., Saad Alhumaid, Mohammed Garout, et al.. (2022). Evaluation of Hematological, Biochemical Profiles and Molecular Detection of Envelope Gene (gp-41) in Human Immunodeficiency Virus (HIV) among Newly Diagnosed Patients. Medicina. 59(1). 93–93. 3 indexed citations
18.
Halwani, Muhammad A., et al.. (2015). Incidence of Antibiotic Resistance Bacteria in Jeddah's Ministry of Health Hospitals, Saudi Arabia. Advances in Microbiology. 5(12). 780–786. 5 indexed citations
19.
Halwani, Muhammad A., Alison E. Turnbull, Meredith Harris, Frank R. Witter, & Trish M. Perl. (2015). Postdischarge surveillance for infection following cesarean section: A prospective cohort study comparing methodologies. American Journal of Infection Control. 44(4). 455–457. 18 indexed citations
20.
Halwani, Muhammad A., Masoud Solaymani–Dodaran, Hajo Grundmann, Carol Coupland, & Richard Slack. (2006). Cross-transmission of nosocomial pathogens in an adult intensive care unit: incidence and risk factors. Journal of Hospital Infection. 63(1). 39–46. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026